Spontaneous coronary artery dissection in association with cabergoline therapy. Issue 2 (9th February 2021)

• Record Type: Journal Article
• Authors: Saleh, Zia; Koshy, Susan; Sidhu, Vaninder; Opgenorth, Andrea; Senaratne, Janek
• Is Part Of: BMJ case reports. Volume 14:Issue 2(2021)
• Publication Date: 2021-02-09
• Subjects: drugs: endocrine system -- cardiovascular medicine; Medicine -- Case studies -- Periodicals; 610.5
• DOI: 10.1136/bcr-2020-240022
• Languages: English
• ISSNs: 1757-790X

Abstract

Abstract : Spontaneous coronary artery dissection (SCAD) is a rare but increasingly recognised cause of acute coronary syndrome. While numerous risk factors are associated with SCAD, one potential cause is coronary artery vasospasm. The use of cabergoline—an ergot derivative and dopamine agonist that may induce vasospasm—has been associated with SCAD in one other case report worldwide. Here, we describe SCAD in a 37-year-old woman on long-term cabergoline therapy with no other cardiac risk factors. Cabergoline-induced SCAD should be considered in patients presenting with an acute coronary syndrome who are treated with this medication.